Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes

Diabetes

Volumn 49, Issue 2, 2000, Pages 218-224

  Braghi, Simona ^a   Bonifacio, Ezio ^a   Secchi, Antonio ^a,b   Di Carlo, Valerio ^a,b   Pozza, Guido ^a   Bosi, Emanuele ^a,b,c  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; EPITOPE; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN G1; PROTEIN TYROSINE PHOSPHATASE;

ADULT; ALLOTRANSPLANTATION; ARTICLE; AUTOIMMUNITY; CELL DESTRUCTION; CONTROLLED STUDY; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0033958643     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.2.218     Document Type: Article

References (31)

1. Bach JF: Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516-542, 1995
2. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, Gale AEM, Bosi E: Islet autoantibody markers in insulin-dependent diabetes: risk assessment strategies yielding high sensitivity. Diabetologia 38:816-822, 1995
3. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, Dahlquist G, Palmer J, Lernmark A: Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 95:1505-1511, 1995
4. Ziegler AG, Hummel M, Schenker M, Bonifacio E: Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460-468, 1999
5. Bonifacio E, Bingley PJ, Dean BM, Shattock M, Dunger D, Gale EAM, Bottazzo GF: Quantification of islet cell antibodies and prediction of insulin-dependent diabetes. Lower 335:147-149, 1990
6. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA, Schwartz S, Malone J, Shah S, Vadheim C, Rotter JI: A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323:1167-1172, 1990
7. Dittler J, Seidel D, Schenker M, Ziegler AG: GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes 47:592-598, 1998
8. Pastore MR, Bazzigaluppi E, Bonfanti R, Dozio N, Sergi A, Balini A, Belloni C, Meschi F, Bonifacio E, Bosi E: Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives. Diabetes Care 21:1445-1450, 1998
9. Lendrum R, Walker G, Cudworth AG, Theophanides C, Pyke DA, Bloom A, Gamble DR: Islet-cell antibodies in diabetes mellitus. Lancet ii:1273-1276, 1976
10. Kolb H, Dannehl D, Zielasek J, Bertrams J, Hubinger A, Gries FA: Prospective analysis of islet cell antibodies in children with type I (insulin-dependent) diabetes. Diabetologia 31:189-194, 1988
11. Bosi E, Andreotti AC, Girardi AM, Bottazzo GF, Pozza G: The long-term persistence of islet cell antibodies in type 1 diabetic patients is unrelated to residual β-cell function. Diabetes Nutr Metab 4:319-323, 1991
12. Savola K, Sabbah E, Kulmala P, Ilonen J, Knip M: Autoantibodies associated with type 1 diabetes mellitus persist after diagnosis in children. Diabetologia 41:1293-1297, 1998
13. Robertson RP, Sutherland DER, Lanz KJ: Normoglycemia and preserved insulin secretory reserve in diabetic patients 10-18 years after pancreas transplantation. Diabetes 48:1737-1740, 1999
14. Sibley RK, Sutherland DER, Goetz F, Michael AF: Recurrent diabetes mellitus in the pancreas iso- and allograft: a light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 53:132-144, 1985
15. Sibley RK, Sutherland DER: Pancreas transplantation: an immunohistologic and histopathologic examination of 100 grafts. Am J Pathol 128:151-170, 1987
16. Sutherland DER, Goetz FC, Sibley RK: Recurrence of disease in pancreas transplants. Diabetes 38 (Suppl. 1):85-87, 1989
17. Tyden G, Reinholt FP, Sundkvist G, Bolinder J: Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 335:860-863, 1996
18. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
19. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Oles J, Hicks JM, Goldstein DE, Rae PMM: Islet cell antigen 512 is a diabetes-specific autoantigen related to protein tyrosine phosphatases. J Immunol 152:3183-3188, 1994
20. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E: Identification of protein tyrosine phosphatase-like IA-2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 155:5419-5426, 1995
21. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS, participating laboratories: Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, and cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857-1866, 1998
22. Naserke HE, Dozio N, Ziegler AG, Bonifacio E: Comparison of a novel microassay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia 41:681-683, 1998
23. Lampasona V, Bearzatto M, Genovese S, Bosi E, Ferrari M, Bonifacio E: Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosin phosphatase-like IA-2 autoantigen. J Immunol 157:2707-2711, 1996
24. Bonifacio E, Lampasona V, Bingley PJ: IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens. J Immunol 161:2648-2654, 1998
25. Naserke HE, Ziegler AG, Lampasona V, Bonifacio E: Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. J Immunol 161:6963-6969, 1998
26. Bonifacio E, Scirpoli M, Kredel K, Fuchtenbusch M, Ziegler AG: Early autoantibody responses in pre-diabetes are IgG1 dominated and suggest antigen-specific regulation. J Immunol 163:525-532, 1999
27. Bosi E, Bottazzo GF, Secchi A, Pozza G, Shattock M, Saunders A, Gelet A, Touraine JL, Traeger J, Dubernard JM: Islet cell autoimmunity in type 1 diabetic patients after HLA-mismatched pancreas transplantation. Diabetes 38 (Suppl. 1):82-84, 1989
28. Esmatjes E, Rodriguez-Villar C, Ricart MJ, Casamitjana R, Martorell J, Sabater L, Astudillo E, Fernandez-Cruz L: Recurrence of immunological markers for type 1 (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation. Transplantation 66:128-131, 1998
29. Sundkvist G, Tyden G, Karlsson FA, Bolinder J: Islet autoimmunity before and after pancreas transplantation in patients with type 1 diabetes mellitus. Diabetologica 41:1532-1533, 1998
30. Jaeger C, Brendel MD, Hering BJ, Eckhard M, Bretzel RG: Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes 46:1907-1910, 1997
31. De Filippo G, Carel JC, Boitard C, Bougnères PF: Long-term results of early cyclosporin therapy in juvenile IDDM. Diabetes 45:101-104, 1996